These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

638 related items for PubMed ID: 29020498

  • 1. LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4.
    Hu B, Zhang H, Wang Z, Zhang F, Wei H, Li L.
    Cancer Biol Ther; 2017 Dec 02; 18(12):974-983. PubMed ID: 29020498
    [Abstract] [Full Text] [Related]

  • 2. NORAD accelerates chemo-resistance of non-small-cell lung cancer via targeting at miR-129-1-3p/SOX4 axis.
    Huang Q, Xing S, Peng A, Yu Z.
    Biosci Rep; 2020 Jan 31; 40(1):. PubMed ID: 31894841
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
    Tian LJ, Wu YP, Wang D, Zhou ZH, Xue SB, Zhang DY, Wei YG, Liu W.
    Med Sci Monit; 2019 Oct 29; 25():8095-8104. PubMed ID: 31659146
    [Abstract] [Full Text] [Related]

  • 4. Circular RNA circ-RNF121 contributes to cisplatin (DDP) resistance of non-small-cell lung cancer cells by regulating the miR-646/SOX4 axis.
    Liu Y, Zhai R, Hu S, Liu J.
    Anticancer Drugs; 2022 Jan 01; 33(1):e186-e197. PubMed ID: 34387608
    [Abstract] [Full Text] [Related]

  • 5. LncRNA SNHG14 regulates the DDP-resistance of non-small cell lung cancer cell through miR-133a/HOXB13 pathway.
    Xu L, Xu Y, Yang M, Li J, Xu F, Chen BL.
    BMC Pulm Med; 2020 Oct 15; 20(1):266. PubMed ID: 33059643
    [Abstract] [Full Text] [Related]

  • 6. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving.
    Wang DY, Li N, Cui YL.
    Cancer Res Treat; 2020 Jul 15; 52(3):798-814. PubMed ID: 32124583
    [Abstract] [Full Text] [Related]

  • 7. Identification of circ_0058357 as a regulator in non-small cell lung cancer cells resistant to cisplatin by miR-361-3p/ABCC1 axis.
    Chu D, Li P, Li Y, Shi J, Huang S, Jiao P.
    Thorac Cancer; 2021 Nov 15; 12(21):2894-2906. PubMed ID: 34523261
    [Abstract] [Full Text] [Related]

  • 8. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
    Ge P, Cao L, Zheng M, Yao Y, Wang W, Chen X.
    Exp Mol Pathol; 2021 Jun 15; 120():104633. PubMed ID: 33753110
    [Abstract] [Full Text] [Related]

  • 9. Long non-coding RNA SNHG1 contributes to cisplatin resistance in non-small cell lung cancer by regulating miR-140-5p/Wnt/β-catenin pathway.
    Shi SL, Zhang ZH.
    Neoplasma; 2019 Sep 15; 66(5):756-765. PubMed ID: 31288529
    [Abstract] [Full Text] [Related]

  • 10. miR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549.
    Deng SH, Wu DM, Li L, Liu T, Zhang T, Li J, Yu Y, He M, Zhao YY, Han R, Xu Y.
    Biochem Biophys Res Commun; 2021 Apr 16; 549():54-60. PubMed ID: 33662669
    [Abstract] [Full Text] [Related]

  • 11. Long non-coding RNA ROR regulated ABCB1 to induce cisplatin resistance in osteosarcoma by sponging miR-153-3p.
    Cheng FH, Zhao ZS, Liu WD.
    Eur Rev Med Pharmacol Sci; 2019 Sep 16; 23(17):7256-7265. PubMed ID: 31539112
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis.
    Wang L, Shang X, Feng Q.
    Cancer Biol Ther; 2019 Sep 16; 20(3):261-271. PubMed ID: 30481109
    [Abstract] [Full Text] [Related]

  • 15. [Role of SOX4 on DDP Resistance in Non-small Cell Lung Cancer Cell of A549].
    Li W, Liu X, Zhang G, Zhang L.
    Zhongguo Fei Ai Za Zhi; 2017 May 20; 20(5):298-302. PubMed ID: 28532536
    [Abstract] [Full Text] [Related]

  • 16. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
    Xie X, Liu W, Duan Z, Li X, Zhang L, Yang G.
    Cell Mol Biol (Noisy-le-grand); 2020 Jun 05; 66(3):143-148. PubMed ID: 32538761
    [Abstract] [Full Text] [Related]

  • 17. CircRNA_100565 contributes to cisplatin resistance of NSCLC cells by regulating proliferation, apoptosis and autophagy via miR-337-3p/ADAM28 axis.
    Zhong Y, Lin H, Li Q, Liu C, Shen J.
    Cancer Biomark; 2021 Jun 05; 30(2):261-273. PubMed ID: 33682697
    [Abstract] [Full Text] [Related]

  • 18. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
    Qiao CY, Qiao TY, Jin H, Liu LL, Zheng MD, Wang ZL.
    Eur Rev Med Pharmacol Sci; 2020 Jan 05; 24(1):200-212. PubMed ID: 31957833
    [Abstract] [Full Text] [Related]

  • 19. The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells.
    Guo J, Jin D, Wu Y, Yang L, Du J, Gong K, Chen W, Dai J, Miao S, Xi S.
    EBioMedicine; 2018 Sep 05; 35():204-221. PubMed ID: 30146342
    [Abstract] [Full Text] [Related]

  • 20. Circ_0020123 enhances the cisplatin resistance in non-small cell lung cancer cells partly by sponging miR-140-3p to regulate homeobox B5 (HOXB5).
    Wei D, Zeng J, Rong F, Xu Y, Wei R, Zou C.
    Bioengineered; 2022 Mar 05; 13(3):5126-5140. PubMed ID: 35170372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.